3rd Covalent Drug Discovery and Development Summit
By
Hanson Wade
4 Followers
Follow
Event Details
3rd Covalent Drug Discovery and Development Summit
2025 marks an exciting phase for covalent drugs, with the field doubling down on de-risked assets and tackling high-value targets in oncology, immunology, and beyond. With MOMA Therapeutics recently dosing their first patient with a covalent Werner helicase inhibitor, and Novartis partnering with covalent pioneer Matchpoint Therapeutics in a $60 million deal, it's clear that the therapeutic potential of covalency is growing.
The 3rd Covalent Drug Discovery and Development Summit returns as the premier industry forum for experts to accelerate the discovery, translation and development of covalent drugs, driving the next wave of first- and best-in-class therapeutics against previously undruggable targets.
The 3rd Covalent Drug Discovery and Development Summit returns as the premier industry forum for experts to accelerate the discovery, translation and development of covalent drugs, driving the next wave of first- and best-in-class therapeutics against previously undruggable targets.
Entry Fees
Free Registration
Categories
Event Frequency
One Time
Event Timings
(GMT-5:00) Central Time (US and Canada)
09:00 AM - 03:15 PM (Dec 09, Dec 10, Dec 11) (General)
Speakers
Organizer
Hanson Wade
4 Followers
Follow
Hanson Wade specialises in bringing people together through outstanding business conferences and year round community contact.
Tags
Comments on 3rd Covalent Drug Discovery and Development Summit
You must Login to write a comment.
Peoples Interested in Visit
0 Peoples Interested to Visit
Event Location
Revere Hotel Boston Common
200, Stuart Street, Bay Village, Boston ,
Boston 02116, Massachusetts, United States
Boston 02116, Massachusetts, United States
Official Link :